Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9281925 | Médecine et Maladies Infectieuses | 2005 | 8 Pages |
Abstract
The spread of multiresistant Staphylococcus and Enterococcus strains required the development of new drugs. Linezolid is the first molecule of a new antibiotic family, oxazolidinones, with an original mechanism of action. In this general review, the authors first present its antibacterial activity, its pharmacokinetic properties, its therapeutic uses in serious Gram-positive infections, pneumonia, skin and soft tissue infections, and also in other indications. They then explain the rules for administration and tolerability.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Infectious Diseases
Authors
H. Dutronc, F. Bocquentin, T. Galpérine, S. Lafarie-Castet, M. Dupon,